Secreted protein acidic and rich in cysteine (SPARC) and a disintegrin and metalloproteinase with thrombospondin type 1 motif (ADAMTS1) increments by the renin-angiotensin system induce renal fibrosis in deoxycorticosterone acetate-salt hypertensive rats

Eur J Pharmacol. 2022 Jan 5:914:174681. doi: 10.1016/j.ejphar.2021.174681. Epub 2021 Dec 4.

Abstract

Secreted protein acidic and rich in cysteine (SPARC), an extracellular matrix (ECM) protein, was recently shown to induce collagen deposition through the production of a disintegrin and metalloproteinase with thrombospondin type 1 motif (ADAMTS1) in the aging heart. ADAMTS1 regulates ECM turnover by degrading ECM components, and its excessive activation contributes to various pathological states, including fibrosis. The present study investigated the pathophysiological regulation and role of SPARC and ADAMTS1 in renal fibrosis using uninephrectomized rats treated with deoxycorticosterone acetate (DOCA, 40 mg/kg/week, subcutaneously) and salt (1% in drinking water). The administration of DOCA and salt gradually and significantly elevated systolic blood pressure during the 3-week treatment period, induced proteinuria, decreased creatinine clearance, and increased NADPH oxidase-derived superoxide production, malondialdehyde concentrations, and monocyte chemoattractant protein-1 and osteopontin expression in the kidneys. Glomerulosclerosis, fibrillar collagen deposition, and transforming growth factor-β expression increased in a time-dependent manner, and SPARC and ADAMTS1 expression showed a similar pattern to these changes. The angiotensin II type-1 receptor blocker losartan suppressed the overexpression of SPARC and ADAMTS1, and an in vitro exposure to angiotensin II induced the production of both SPARC and ADAMTS1 in renal fibroblast NRK-49F cells. Knockdown of the SPARC gene with small interfering RNA reduced all forms (the 110-kDa latent and 87- and 65-kDa bioactive forms) of ADAMTS1 expression as well as collagen production. These results suggest that SPARC is induced by the renin-angiotensin system and may be a fibrogenic factor, at least in part, by producing ADAMTS1 in hypertensive renal disease.

Keywords: Angiotensin II; Extracellular matrix; Fibrosis; Secreted protein acidic and rich in cysteine.

MeSH terms

  • ADAMTS1 Protein / metabolism*
  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Animals
  • Desoxycorticosterone Acetate / pharmacology
  • Extracellular Matrix Proteins / metabolism
  • Fibrillar Collagens* / biosynthesis
  • Fibrillar Collagens* / metabolism
  • Fibrosis / metabolism
  • Glomerulosclerosis, Focal Segmental / etiology
  • Glomerulosclerosis, Focal Segmental / metabolism
  • Glomerulosclerosis, Focal Segmental / physiopathology
  • Hypertension / chemically induced
  • Hypertension / metabolism
  • Kidney* / metabolism
  • Kidney* / pathology
  • Losartan / pharmacology*
  • Mineralocorticoids / pharmacology
  • Osteonectin / metabolism*
  • Rats
  • Renin-Angiotensin System* / drug effects
  • Renin-Angiotensin System* / physiology
  • Sodium Chloride, Dietary / administration & dosage

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Extracellular Matrix Proteins
  • Fibrillar Collagens
  • Mineralocorticoids
  • Osteonectin
  • Sodium Chloride, Dietary
  • Desoxycorticosterone Acetate
  • ADAMTS1 Protein
  • Adamts1 protein, rat
  • Losartan